HAMID, O.; LEWIS, K.; WEISE, A.; MCKEAN, M.; PAPADOPOULOS, K. P.; CROWN, J.; KIM, T. M.; LAKHANI, N. J.; KACZMAR, J.; KUDCHADKAR, R.; SPIRA, A.; RABINOWITS, G.; KIM, K.; CARVAJAL, R.; WILLIAMSON, S.; IOFFE, E.; CHEN, S.; MANI, J.; JANKOVIC, V.; BRENNAN, L.; KROOG, G.; SIMS, T.; LOWY, I.; GULLO, G. Phase 1 study of fianlimab, a human lymphocyte activation gene-3 monoclonal antibody, in combination with cemiplimab in advanced melanoma: Expansion cohort analysis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 2, p. s179, 2023. DOI: 10.25251/skin.7.supp.179. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/1997. Acesso em: 4 jul. 2024.